Shunichiro Taniguchi
Corporate Officer/Principal bei Shinshu University
Profil
Shunichiro Taniguchi is the founder of Anaeropharma Science, Inc. which was founded in 2004.
He held the title of Director from 2010 to 2013.
Currently, he is a Professor at Shinshu University.
Previously, he was a Professor at Kyushu University.
Dr. Taniguchi received his undergraduate and doctorate degrees from Kyushu University.
Aktive Positionen von Shunichiro Taniguchi
Unternehmen | Position | Beginn |
---|---|---|
Shinshu University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Shunichiro Taniguchi
Unternehmen | Position | Ende |
---|---|---|
Kyushu University | Corporate Officer/Principal | - |
Anaeropharma Science, Inc.
Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Gründer | - |
Ausbildung von Shunichiro Taniguchi
Kyushu University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Anaeropharma Science, Inc.
Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Health Technology |